A real-time calibration to enhance the inter-subject reproducibility of insulin bioavailability measurements was proposed and validated on a diabetic patient with more than 49000 impedance values. The measurement method monitors drug absorption through a transducer consisting of a sensitive material (human abdominal tissue) and an impedance spectrometer. The in-vivo experiments revealed a statistically significant negative second-order polynomial trend in impedance magnitude corresponding to the amount of rapid-acting insulin injected. To manage the uncertainty inherent in the sensing block, the method integrates real-time calibration. Implementing a real-time calibration method based on a customized model identification at each insulin administration resulted in a reduction in deterministic error by a factor of 18. A further reduction in deterministic error for clinical application (46%) was achieved with a customized parameter second-order polynomial model with respect to the customized parameter linear model. Lastly, when less conductive long-acting insulin was administered, an increasing trend in impedance magnitude was observed, aligned with the theoretical framework of the proposed method.
No takes yet. Share an insight, caveat, or question.
Arpaïa et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: